Drug Topics

APRIL 16, 2025

At AAP 2025, Douglas Hoey, RPh, MBA, CEO of NCPA, discussed what pharmacies can do to increase revenue and avoid shutting their doors.

Independent Pharmacies 465

Independent Pharmacies 465

STAT

APRIL 17, 2025

For a decade and a half, Americans have been guaranteed that no matter their health insurer, certain preventive care like cancer screenings are free of charge. That’s because an Affordable Care Act provision has required insurers to fully cover services given an A or B recommendation by an expert task force. That may soon change. On Monday, the U.S.

Insurance 139

Insurance 139

Drug Topics

APRIL 14, 2025

Furthermore, C-reactive protein has greater prognosis for lung cancer, colorectal cancer, and ovarian cancer.

484

484

STAT

APRIL 14, 2025

Dozens of state attorneys general are urging Congress to pass a law prohibiting pharmacy benefit managers from simultaneously owning pharmacies, arguing such a move would boost competition and create more affordable prescription drug prices for Americans. Their concern is these arrangements create conflicts of interest that allow pharmacy benefits managers to dominate the design of health plans for tens of millions of Americans, and also distort the distribution and pricing for prescription medi

Health Care Clinics 141

Health Care Clinics Insurance 141

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

PharmaVoice

APRIL 16, 2025

Lower operating costs and a supply of high-skilled workers are helping the North Carolina region pull in billions of pharma manufacturing investments.

243

243

The Checkup by Singlecare

APRIL 15, 2025

Many people are interested in generic drug availability since brand-name drugs are often costly. Mounjaro (tirzepatide) is a brand-name prescription medication that is approved by the Food and Drug Administration (FDA) to improve blood sugar levels in people with Type 2 diabetes. It is also commonly used off-label for weight loss because, as a dual glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist, tirzepatide helps control appetite

Compounding 85

Compounding Dosage Compounding Pharmacies FDA 85

STAT

APRIL 15, 2025

A new federal report suggests that U.S. autism rates are rising modestly, an increase that health researchers said reflected expanded diagnostic tools and access to care, among other factors. But health secretary Robert F. Kennedy Jr. instead has pointed to the data as evidence of a growing crisis. The Centers for Disease Control and Prevention report says that 3.2% of kids surveyed in 2022 have autism spectrum disorder, a slight uptick from the 2.8% of kids surveyed in 2020 for the previous rep

144

144

PharmaVoice

APRIL 14, 2025

Major changes to the dynamics of the pharmaceutical ecosystem are making executive decisions even tougher.

223

223

Hospital Pharmacy Europe

APRIL 17, 2025

As an overall patient safety and medicines quality measure, hospital pharmacists in Belgium have mitigated critical risks in the supply chain for chimeric antigen receptor (CAR) T-cell therapies. Advanced therapy medicinal products (ATMPs), such as CAR T-cell therapies, are innovative biological drugs that demand careful management of complex supply chains.

Hospitals 59

Hospitals 59

European Pharmaceutical Review

APRIL 21, 2025

For the first time in over ten years, the US Food and Drug Administration (FDA) has approved a new targeted treatment for chronic spontaneous urticaria. Sanofi and Regeneron Pharmaceuticals collaborated to develop Dupixent (dupilumab). Under the FDA’s new authorisation, the therapy is indicated for individuals aged 12 years and over with the chronic inflammatory skin disease, who still experience symptoms despite taking histamine-1 (H1) antihistamine medication.

FDA 59

FDA 59

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Drug Topics

APRIL 15, 2025

On behalf of 39 state and territory attorneys general, the National Association of Attorneys General issued a letter to Congress regarding major PBMs conflicts of interest.

463

463

PharmaVoice

APRIL 18, 2025

Compass Pathways expects to publish the first phase 3 results from a large-scale, psilocybin drug trial by the end of this quarter.

208

208

Pharma Marketing Network

APRIL 16, 2025

Imagine launching a brand campaign without guessworkwhere your message reaches the right healthcare professional at the right time on the right channel. Thats the promise of data-driven marketing , a strategy thats rapidly transforming how pharmaceutical companies approach promotion, education, and engagement in 2025. As privacy regulations evolve, customer expectations change, and AI-driven technologies emerge, pharma marketers must adapt or risk becoming irrelevant.

HIPAA 59

HIPAA Documentation Pharmaceutical Companies Pharmaceutical Companies 59

The Checkup by Singlecare

APRIL 21, 2025

Symbicort is a drug that healthcare professionals prescribe to treat asthma and chronic obstructive pulmonary disease (COPD). It contains two active ingredients: budesonide and formoterol fumarate dihydrate. Budesonide is a long-acting inhaled corticosteroid that helps relieve inflammation in the lungs and airways, while formoterol is a long-acting beta-2 agonist (LABA) that helps keep the airways open (a bronchodilator) by relaxing the smooth muscles around them.

Dosage 52

Dosage Insurance Immunization FDA 52

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Drug Topics

APRIL 17, 2025

The subgroup analysis shows adolescents treated with the drug once daily had higher rates of clear or almost clear skin compared to patients receiving the placebo.

405

405

STAT

APRIL 17, 2025

WASHINGTON — The Food and Drug Administration will remove industry representatives from advisory committees and replace them with patients and caregivers, Commissioner Marty Makary announced Thursday.  While that’s not really a big change, it’s the latest effort by Makary and his boss, health secretary Robert F. Kennedy Jr., to reduce the influence of the pharmaceutical industry.

FDA 145

FDA 145

PharmaVoice

APRIL 21, 2025

SpringWorks Therapeutics and the Children’s Tumor Foundation salvaged a shelved asset for neurofibromatosis and got it over the regulatory finish line.

147

147

European Pharmaceutical Review

APRIL 21, 2025

Quality-by-design (QbD) is a systemic risk-management strategy that facilitates the production of safe and consistent drugs. As pharma and biotech companies move towards more complex medicines, it is critical they have contract development and manufacturing organisation (CDMO) partners who can implement QbD principles while maintaining the accelerated timelines required for competitive business.

Customer Service 52

Customer Service FDA 52

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

The Checkup by Singlecare

APRIL 18, 2025

Levetiracetam , known by the brand name Keppra, is an important medication for many people who live with seizure disorders. If youve been prescribed levetiracetam, its usually on a long-term basis so you might wonder about drinking alcohol while attending social events or simply unwinding after work. Unfortunately, mixing alcohol with levetiracetam is generally not recommended as it can increase side effects like drowsiness and dizziness or increase the risk of seizures.

Dosage 52

Dosage Labelling 52

Drug Topics

APRIL 14, 2025

At AAP 2025, Ron Friedman discussed best practices for responding to a DEA inspection, how to identify any red flags, and best practices for dispensing.

Independent Pharmacies 394

Independent Pharmacies 394

STAT

APRIL 17, 2025

A daily pill from Eli Lilly helped patients with type 2 diabetes improve their blood sugar and shed weight, the company said Thursday, results that could propel the next-generation treatment onto the market. The drug, orforglipron, produced results that were nearly comparable to the benefits of available GLP-1 drugs, which are weekly injectable treatments.

128

128

PharmaVoice

APRIL 17, 2025

The non-traditional marketing approach comes amid a potential crackdown on TV drug ads.

147

147

Pharma Marketing Network

APRIL 21, 2025

Introduction In the ever-evolving world of healthcare promotion, pharma brands are constantly seeking reliable, cost-effective, and targeted strategies to stay connected with healthcare professionals (HCPs) and patients. Enter email marketing campaigns a digital tactic that’s proving to be more than just effective. But are these campaigns truly worth the investment in 2025’s competitive and compliance-heavy landscape?

52

52

The Checkup by Singlecare

APRIL 18, 2025

Research shows that men are generally more susceptible to seizures than women, and gabapentin (sold under the brand names Neurontin and Gralise ) is one of the most common anticonvulsant medications out there. In fact, its kind of a jack-of-all-trades drug, approved by the Food and Drug Administration (FDA) to treat epilepsy, postherpetic neuralgia, and restless leg syndrome.

Adverse Reactions 52

Adverse Reactions Controlled Substances Labelling Compounding 52

Drug Topics

APRIL 14, 2025

With transitions of care inclusive of multiple health care settings, each provider must play a specific role to ensure overall improved patient outcomes.

389

389

STAT

APRIL 17, 2025

Even before the Department of Health and Human Services announced its recent major reorganization, the media had been reporting on anticipated changes to the Centers for Disease Control and Prevention, the Food and Drug Administration, and the National Institutes of Health. But the very last bullet on the HHS fact sheet was a complete surprise to most people: the elimination of the Administration for Community Living (ACL).

115

115

PharmaVoice

APRIL 21, 2025

Five GLP-1 products will collectively bring in $470 billion by 2030, and the market leaders are working to hold back competition.

130

130

Pharma Marketing Network

APRIL 20, 2025

Introduction In todays fast-evolving healthcare environment, one truth has become increasingly clear: Healthcare Branding is no longer just about recognition; it’s about trust, authenticity, and relevance. As the healthcare sector shifts under the weight of new technologies, regulatory changes, and consumer demands, branding strategies that worked a decade ago are becoming obsolete.

Communication 59

Communication Customer Service 59

Pharmacy Times

APRIL 16, 2025

At 28 to 179 days, COVID-19 infection in patients with preexisting chronic kidney disease (CKD) was associated with an increased risk of composite kidney events.

129

129

Drug Topics

APRIL 15, 2025

The FDA approved adalimumab-aaty in May 2023 for 8 indications, including rheumatoid arthritis, psoriatic arthritis, Crohn disease, ulcerative colitis, and plaque psoriasis.

FDA 380

FDA 380

STAT

APRIL 15, 2025

A  meeting of vaccine advisers long targeted by Health Secretary Robert F. Kennedy Jr. unfolded Tuesday seemingly without fireworks or interference, although the new administration’s imprint could be seen from the start, when staff for the Centers for Disease Control and Prevention, gutted by layoffs, struggled to get a livestream running.

Vaccines 111

Vaccines Communication 111

PharmaVoice

APRIL 15, 2025

Brian Thompson’s murder has raised questions about the cost of U.S. healthcare, embroiling insurers, drugmakers and PBMs in a battle for the future of the industry.

Insurance 130

Insurance 130

Pharma Marketing Network

APRIL 17, 2025

What do you do when the traditional pillars of your marketing strategy start to crumble? For many pharmaceutical companies in 2025, the answer is clear: pivot aggressively toward digital. With geopolitical volatility sparking new tariff threats and mounting legislative scrutiny over pharmaceutical television ads, pharma digital ad spend is experiencing a noticeable surge.

HIPAA 59

HIPAA Compounding Pharmaceutical Companies Pharmaceutical Companies 59